Literature DB >> 23066512

Methamphetamine Cured my Cocaine Addiction.

Colin N Haile1, Richard De La Garza, Thomas F Newton.   

Abstract

Cocaine dependence is an enduring problem and years of research and drug development has yet to produce an efficacious pharmacotherapy. Recent clinical research suggests that chronic treatment with amphetamine-like medications produces tolerance to cocaine's reinforcing effects and may offer a viable pharmacotherapy. Three methamphetamine-dependent participants that had been in our clinical laboratory experiments and previously addicted to cocaine are reviewed. Data obtained from initial screen and informal conversation suggested that all participants considered methamphetamine to have helped them stop using cocaine and eliminate cocaine craving. Methamphetamine also significantly decreased their alcohol consumption but did not alter cannabis or nicotine use.

Entities:  

Year:  2010        PMID: 23066512      PMCID: PMC3467950          DOI: 10.4172/2155-6105.1000103

Source DB:  PubMed          Journal:  J Addict Res Ther


  15 in total

Review 1.  Lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of ADHD in children and adults.

Authors:  Gregory Mattingly
Journal:  CNS Spectr       Date:  2010-05       Impact factor: 3.790

2.  Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys.

Authors:  S Stevens Negus; Nancy K Mello
Journal:  Drug Alcohol Depend       Date:  2003-05-01       Impact factor: 4.492

3.  Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys.

Authors:  Paul W Czoty; Jennifer L Martelle; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2010-03-09       Impact factor: 4.530

4.  Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial.

Authors:  J Grabowski; H Rhoades; J Schmitz; A Stotts; L A Daruzska; D Creson; F G Moeller
Journal:  J Clin Psychopharmacol       Date:  2001-10       Impact factor: 3.153

5.  The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans.

Authors:  Thomas F Newton; Richard De La Garza; Ken Grasing
Journal:  Psychiatry Res       Date:  2010-05-20       Impact factor: 3.222

6.  Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.

Authors:  S S Negus; N K Mello; B E Blough; M H Baumann; R B Rothman
Journal:  J Pharmacol Exp Ther       Date:  2006-10-27       Impact factor: 4.030

7.  Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.

Authors:  N D Volkow; G J Wang; J S Fowler; S J Gatley; Y S Ding; J Logan; S L Dewey; R Hitzemann; J Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.

Authors:  Marc E Mooney; David V Herin; Joy M Schmitz; Nidal Moukaddam; Charles E Green; John Grabowski
Journal:  Drug Alcohol Depend       Date:  2008-12-05       Impact factor: 4.492

Review 9.  New treatments for cocaine dependence: a focused review.

Authors:  Laurent Karila; David Gorelick; Aviv Weinstein; Florence Noble; Amine Benyamina; Sarah Coscas; Lisa Blecha; William Lowenstein; Jean Luc Martinot; Michel Reynaud; Jean Pierre Lépine
Journal:  Int J Neuropsychopharmacol       Date:  2007-10-10       Impact factor: 5.176

10.  Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol.

Authors:  S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2003-03-05       Impact factor: 7.853

View more
  3 in total

1.  Unique genetic factors influence sensitivity to the rewarding and aversive effects of methamphetamine versus cocaine.

Authors:  Noah R Gubner; Cheryl Reed; Carrie S McKinnon; Tamara J Phillips
Journal:  Behav Brain Res       Date:  2013-08-28       Impact factor: 3.332

Review 2.  Agonist Medications for the Treatment of Cocaine Use Disorder.

Authors:  S Stevens Negus; Jack Henningfield
Journal:  Neuropsychopharmacology       Date:  2014-12-11       Impact factor: 7.853

Review 3.  Pharmacotherapy for stimulant-related disorders.

Authors:  Colin N Haile; Thomas R Kosten
Journal:  Curr Psychiatry Rep       Date:  2013-11       Impact factor: 5.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.